Mutual of America Capital Management LLC Decreases Position in Agilent Technologies, Inc. $A

Mutual of America Capital Management LLC lessened its holdings in Agilent Technologies, Inc. (NYSE:A) by 10.2% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 42,860 shares of the medical research company’s stock after selling 4,876 shares during the period. Mutual of America Capital Management LLC’s holdings in Agilent Technologies were worth $5,058,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in A. Stone House Investment Management LLC purchased a new position in Agilent Technologies in the 1st quarter valued at approximately $30,000. Ransom Advisory Ltd purchased a new position in Agilent Technologies in the 1st quarter valued at approximately $32,000. Central Pacific Bank Trust Division purchased a new stake in shares of Agilent Technologies during the 2nd quarter worth $33,000. Zions Bancorporation National Association UT purchased a new stake in shares of Agilent Technologies during the 1st quarter worth $38,000. Finally, Costello Asset Management INC purchased a new stake in shares of Agilent Technologies during the 1st quarter worth $47,000.

Agilent Technologies Trading Up 2.0%

NYSE A opened at $145.79 on Wednesday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The firm has a market cap of $41.33 billion, a PE ratio of 34.22, a P/E/G ratio of 4.67 and a beta of 1.26. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $153.84. The firm’s fifty day moving average is $128.72 and its two-hundred day moving average is $118.37.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting analysts’ consensus estimates of $1.37. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. Agilent Technologies’s quarterly revenue was up 10.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 30th. Agilent Technologies’s payout ratio is 23.24%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on A shares. UBS Group raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $130.00 to $170.00 in a research report on Wednesday, October 8th. Barclays boosted their price target on shares of Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a research report on Thursday, October 2nd. Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. Wells Fargo & Company boosted their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a research report on Monday, September 15th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $149.62.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.